🔎 Trials Near Me

Utama › Skizofrenia › Nebraska

Kajian klinikal Skizofrenia di Nebraska

6 kajian untuk Skizofrenia sedang mencari peserta di lokasi di Nebraska.

Bandar di Nebraska

Teks kajian rasmi (Bahasa Inggeris)

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  • Local Institution - 0020, Grand Island
  • Omaha Insomnia and Psychiatric Services, Omaha
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07101094

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Alivation Research LLC, Lincoln
Mengambil pesertaFasa 3
Umur 5 hingga 17 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06229210

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0147, Lincoln
Mengambil pesertaFasa 3
Umur 5 hingga 17 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07424404

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Omaha
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07105111

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Local Institution - 0041, Lincoln
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  • Alkermes Investigator Site, Lincoln
Mengambil pesertaFasa 3
Umur 10 hingga 17 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT05303064

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.